The Government of Hungary has officially opened applications for the Stipendium Hungaricum Scholarship 2026/2027. The program invites international ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic T-cell infiltration and reducing immunosuppressive ...

Roushan Jahan, one of the pioneer researchers on women’s empowerment, passed away on Tuesday, November 4, 2025. She was my ...

Canada is set to exempt master's and doctoral students at public universities from study permit caps from January 2026. This ...

The Southern African Large Telescope (SALT) celebrates 20 years of observing the sky. SALT is the largest optical telescope in the southern hemisphere. It’s been steadily revealing new science ...

Cancer survivors across the country are turning painful reminders of treatment into powerful symbols of resilience. Through ...

First data on Aptevo's new molecule presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting SEATTLE, WASHINGTON / ACCESS Newswire / November 10, 2025 / Aptevo Therapeutics ("Aptevo" ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Duran is also the author of the forthcoming non-fiction book The Nerd Reich: Silicon Valley Fascism and the War on Global ...

The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses compared to teriflunomideIn a pivotal PPMS study ...

HAMLET BioPharma, a clinical-stage biopharmaceutical company advancing targeted oncological and other therapies, today announced it has received written feedback from the U.S. Food and Drug ...